2 Incredible Growth Stocks to Buy Hand Over Fist [Yahoo! Finance]
Kura Oncology, Inc. (KURA)
Last kura oncology, inc. earnings: 2/25 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.kuraoncology.com/investor-relations
Company Research
Source: Yahoo! Finance
While this trend is a reversal relative to historical norms, growth stocks are likely to continue to deliver outstanding returns over the long term due to the emergence of powerful secular trends in healthcare, information technology, and alternative energy, among other areas of the global economy. Which growth stocks are worthy of consideration right now? Kura Oncology (NASDAQ: KURA) and Hims & Hers Health, Inc. (NYSE: HIMS) have both trounced the S&P 500 through the first five months of 2024, which says a lot given the relative strength of this benchmark index this year. Here's why savvy investors may want to add these two red-hot healthcare stocks to their portfolios right now. The case for buying Kura Oncology stock Kura Oncology, headquartered in San Diego, is a developmental biopharmaceutical company focusing on crafting oral small-molecule drugs aimed at pivotal cancer signaling pathways. This year, Kura's stock has surged by 46% to date, a testament to investor confidenc
Show less
Read more
Impact Snapshot
Event Time:
KURA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KURA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KURA alerts
High impacting Kura Oncology, Inc. news events
Weekly update
A roundup of the hottest topics
KURA
News
- Kura Oncology, Inc. (NASDAQ: KURA) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $32.00 price target on the stock.MarketBeat
- Kura Oncology, Inc. (NASDAQ: KURA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.MarketBeat
- Kura Oncology Completes Enrollment in Registration-Directed Trial of Ziftomenib in NPM1-Mutant AML [Yahoo! Finance]Yahoo! Finance
- Kura Oncology Completes Enrollment in Registration-Directed Trial of Ziftomenib in NPM1-Mutant AMLGlobeNewswire
- Kura Oncology to Participate in Bank of America Securities Healthcare Conference [Yahoo! Finance]Yahoo! Finance
KURA
Earnings
- 5/2/24 - Miss
KURA
Sec Filings
- 5/2/24 - Form SC
- 5/2/24 - Form 10-Q
- 5/2/24 - Form 8-K
- KURA's page on the SEC website